the best part here is they already have FDA approval and the invocell is being adopted and sites growing like wildfire, so its really just a matter of sitting back and watching just how fast the company can grow. Unlike other bio's that are living and dying on their next trial results (of which I own many of those too). This appears to be a very safe and promising investment, all IMHO
6thcents, the volume is picking up today ahead of the conference. I believe investors are researching the attendees and discovering IVOB for the first time.
News 
Market Data 
Discover 
